From Bench to Babies – Drug Development for Male Subfertility

The document explores the challenges and strategies in developing drugs for male subfertility, affecting millions worldwide. Current treatments like IVF and ICSI are costly, necessitating more affordable options. Drug development is hindered by the complexity of sperm function and lack of understanding of male infertility. Recent advancements, such as high-throughput screening and drug repurposing, offer hope, but variability in sperm characteristics and lack of suitable animal models complicate progress. Hormonal therapies and phosphodiesterase inhibitors show mixed results, with limited evidence supporting their efficacy. Antioxidants and dietary supplements have limited impact, and technological advancements present both opportunities and challenges. Drug repurposing, exemplified by AZD5904, shows promise in improving sperm function. Addressing male infertility could improve overall male health and mitigate transgenerational effects. Further research is needed to establish effective treatments.